Michael Van Der Horst | Wacker Biotech Gmbh

Michael Van Der Horst, , Wacker Biotech Gmbh

Michael holds a M.Sc. in (Bio)chemistry, as well as a Ph.D. in Microbiology from the University of Amsterdam, The Netherlands. He continued his academic career as a postdoctoral researcher at universities within The Netherlands and Belgium, and (co-)authored over 35 research papers in peer-reviewed scientific journals. Subsequently he moved on to apply his knowledge of life sciences in consulting, and at the Dutch Food Safety Authority. For the past five years Michael has been working at Wacker Biotech, first as a Process Engineer, and currently as head of the BioProcess Development group. He is directly involved in technology transfer, process development and improvement, scale up, validation and troubleshooting of Wacker Biotech’s customers’ biopharmaceutical production processes.

Appearances:



Day 2, April 8 @ 16:40

Considerations for the process development and cGMP manufacturing of vaccines

last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT
last published: 17/Feb/20 09:15 GMT

back to speakers